1. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. Issue 11 (26th November 2020) Authors: Mahomed, Sharana; Garrett, Nigel; Karim, Quarraisha A; Zuma, Nonhlanhla Y; Capparelli, Edmund; Baxter, Cheryl; Gengiah, Tanuja; Archary, Derseree; Samsunder, Natasha; Rose, Nicole D; Moore, Penny; Williamson, Carolyn; Barouch, Dan H; Fast, Patricia E; Pozzetto, Bruno; Hankins, Catherine; Carlton,... Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial. Issue 7 (3rd July 2019) Authors: Mahomed, Sharana; Garrett, Nigel; Capparelli, Edmund; Baxter, Cheryl; Zuma, Nonhlanhla Yende; Gengiah, Tanuja; Archary, Derseree; Moore, Penny; Samsunder, Natasha; Barouch, Dan H; Mascola, John; Ledgerwood, Julie; Morris, Lynn; Abdool Karim, Salim Journal: BMJ open Issue: Volume 9:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗